P3 HEALTH PARTNERS INC (PIII) Forecast, Price Target & Analyst Ratings

NASDAQ:PIII • US7444132044

Current stock price

2.56 USD
+0.04 (+1.59%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for P3 HEALTH PARTNERS INC (PIII).

Forecast Snapshot

Consensus Price Target

Price Target
$10.71
+ 318.36% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$3.80
Revenue Estimate
405.91M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.71
Upside
+ 318.36%
From current price of $2.56 to mean target of $10.71, Based on 9 analyst forecasts
Low
$8.08
Median
$11.22
High
$13.13

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for PIII. The average price target is 10.71 USD. This implies a price increase of 318.36% is expected in the next year compared to the current price of 2.56.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PIII Current Analyst RatingPIII Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

PIII Historical Analyst RatingsPIII Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
PIII was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PIII.
In the previous month the buy percentage consensus was at a similar level.
PIII was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-02TD CowenMaintains Hold -> Hold
2026-03-27Lake StreetMaintains Buy -> Buy
2025-11-17Lake StreetMaintains Buy -> Buy
2025-04-21Lake StreetMaintains Buy -> Buy
2024-11-20TD CowenMaintains Hold -> Hold
2024-04-01BTIGDowngrade Buy -> Neutral
2024-03-14Lake StreetMaintains Buy -> Buy
2023-09-01BTIGInitiate Buy
2023-06-30TD CowenInitiate Market Perform
2022-01-04William BlairInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$3.80
Revenue Estimate
405.91M
Revenue Q2Q
8.76%
EPS Q2Q
39.42%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
-6.97%
Revenue (3 Months)
-6.97%
EPS (1 Month)
45.86%
EPS (3 Months)
45.86%

Next Earnings Summary

PIII is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -3.8 USD and the consensus revenue estimate is 405.91M USD.
The next earnings revenue estimate has been revised downward by 6.97% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
PIII revenue by date.PIII revenue by date.
1.266B
20.66%		1.5B
18.48%		1.459B
-2.76%		1.579B
8.22%		1.635B
3.55%
EBITDA
YoY % growth
PIII ebitda by date.PIII ebitda by date.
-81.255M
48.77%		-226.542M
-178.80%		-186.138M
17.84%		-33.915M
81.78%		-12.658M
62.68%
EBIT
YoY % growth
PIII ebit by date.PIII ebit by date.
-167.93M
31.71%		-312.6M
-86.15%		-270.301M
13.53%		-107.814M
60.11%		-95.286M
11.62%
Operating Margin
PIII operating margin by date.PIII operating margin by date.
-13.26%-20.83%-18.53%-6.83%-5.83%
EPS
YoY % growth
PIII eps by date.PIII eps by date.
-32.50
78.26%		-46.50
-43.08%		-45.20
2.80%		-21.19
53.13%		-0.27
98.75%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-3.80
39.42%		-2.07
66.76%		-1.54
84.07%		-3.56
84.54%
Revenue
Q2Q % growth		405.91M
8.76%		391.88M
10.14%		378.52M
9.64%		402.54M
9.93%
EBITDA
Q2Q % growth		-11.628M
31.74%		-2.244M
-128.01%		-1.989M
-110.50%		-18.156M
73.95%
EBIT
Q2Q % growth		-8.058M
78.84%		3.876M
111.36%		-24.072M
45.57%		-79.05M
48.62%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PIII Yearly Revenue VS EstimatesPIII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
PIII Yearly EPS VS EstimatesPIII Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -50 -100 -150 -200 -250

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

P3 HEALTH PARTNERS INC / PIII Forecast FAQ

What do analysts expect the price target to be for P3 HEALTH PARTNERS INC (PIII)?

9 analysts have analysed PIII and the average price target is 10.71 USD. This implies a price increase of 318.36% is expected in the next year compared to the current price of 2.56.

When does P3 HEALTH PARTNERS INC (PIII) report earnings?

P3 HEALTH PARTNERS INC (PIII) will report earnings on 2026-05-13.

What are the consensus estimates for P3 HEALTH PARTNERS INC (PIII) next earnings?

The consensus EPS estimate for the next earnings of P3 HEALTH PARTNERS INC (PIII) is -3.8 USD and the consensus revenue estimate is 405.91M USD.

What is the consensus rating for P3 HEALTH PARTNERS INC (PIII) stock?

The consensus rating for P3 HEALTH PARTNERS INC (PIII) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.